Drug Profile
Research programme: pain therapeutics - BIOALVO
Alternative Names: BLV0704; BLV200704; PAIN programme - BIOALVOLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BIOALVO
- Class Analgesics; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Pain
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Portugal (PO)
- 15 Feb 2011 Research programme: pain therapeutics - BIOALVO is available for licensing in World as of 15 Feb 2011. www.bioalvo.com